Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis

Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Na Li, Wenwen Xu, Ying Yuan, Natarajan Ayithan, Yasutomo Imai, Xuesong Wu, Halli Miller, Michael Olson, Yunfeng Feng, Yina H. Huang, Mary Jo Turk, Samuel T. Hwang, Subramaniam Malarkannan, Li Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1b0571cb47a145ed901429ee57439f62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b0571cb47a145ed901429ee57439f62
record_format dspace
spelling oai:doaj.org-article:1b0571cb47a145ed901429ee57439f622021-12-02T11:52:59ZImmune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis10.1038/s41598-017-01411-12045-2322https://doaj.org/article/1b0571cb47a145ed901429ee57439f622017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01411-1https://doaj.org/toc/2045-2322Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory phenotypes. Vsir −/− CD4+ and CD8+ T cells were hyper-responsive towards self- and foreign antigens. Whether or not VISTA regulates innate immunity is unknown. Using a murine model of psoriasis induced by TLR7 agonist imiquimod (IMQ), we show that VISTA deficiency exacerbated psoriasiform inflammation. Enhanced TLR7 signaling in Vsir −/− dendritic cells (DCs) led to the hyper-activation of Erk1/2 and Jnk1/2, and augmented the production of IL-23. IL-23, in turn, promoted the expression of IL-17A in both TCRγδ+ T cells and CD4+ Th17 cells. Furthermore, VISTA regulates the peripheral homeostasis of CD27− γδ T cells and their activation upon TCR-mediated or cytokine-mediated stimulation. IL-17A-producing CD27− γδ T cells were expanded in the Vsir −/− mice and amplified the inflammatory cascade. In conclusion, this study has demonstrated that VISTA critically regulates the inflammatory responses mediated by DCs and IL-17-producing TCRγδ+ and CD4+ Th17 T cells following TLR7 stimulation. Our finding provides a rationale for therapeutically enhancing VISTA-mediated pathways to benefit the treatment of autoimmune and inflammatory disorders.Na LiWenwen XuYing YuanNatarajan AyithanYasutomo ImaiXuesong WuHalli MillerMichael OlsonYunfeng FengYina H. HuangMary Jo TurkSamuel T. HwangSubramaniam MalarkannanLi WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Na Li
Wenwen Xu
Ying Yuan
Natarajan Ayithan
Yasutomo Imai
Xuesong Wu
Halli Miller
Michael Olson
Yunfeng Feng
Yina H. Huang
Mary Jo Turk
Samuel T. Hwang
Subramaniam Malarkannan
Li Wang
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
description Abstract V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) is an inhibitory immune-checkpoint molecule that suppresses CD4+ and CD8+ T cell activation when expressed on antigen-presenting cells. Vsir −/− mice developed loss of peripheral tolerance and multi-organ chronic inflammatory phenotypes. Vsir −/− CD4+ and CD8+ T cells were hyper-responsive towards self- and foreign antigens. Whether or not VISTA regulates innate immunity is unknown. Using a murine model of psoriasis induced by TLR7 agonist imiquimod (IMQ), we show that VISTA deficiency exacerbated psoriasiform inflammation. Enhanced TLR7 signaling in Vsir −/− dendritic cells (DCs) led to the hyper-activation of Erk1/2 and Jnk1/2, and augmented the production of IL-23. IL-23, in turn, promoted the expression of IL-17A in both TCRγδ+ T cells and CD4+ Th17 cells. Furthermore, VISTA regulates the peripheral homeostasis of CD27− γδ T cells and their activation upon TCR-mediated or cytokine-mediated stimulation. IL-17A-producing CD27− γδ T cells were expanded in the Vsir −/− mice and amplified the inflammatory cascade. In conclusion, this study has demonstrated that VISTA critically regulates the inflammatory responses mediated by DCs and IL-17-producing TCRγδ+ and CD4+ Th17 T cells following TLR7 stimulation. Our finding provides a rationale for therapeutically enhancing VISTA-mediated pathways to benefit the treatment of autoimmune and inflammatory disorders.
format article
author Na Li
Wenwen Xu
Ying Yuan
Natarajan Ayithan
Yasutomo Imai
Xuesong Wu
Halli Miller
Michael Olson
Yunfeng Feng
Yina H. Huang
Mary Jo Turk
Samuel T. Hwang
Subramaniam Malarkannan
Li Wang
author_facet Na Li
Wenwen Xu
Ying Yuan
Natarajan Ayithan
Yasutomo Imai
Xuesong Wu
Halli Miller
Michael Olson
Yunfeng Feng
Yina H. Huang
Mary Jo Turk
Samuel T. Hwang
Subramaniam Malarkannan
Li Wang
author_sort Na Li
title Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
title_short Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
title_full Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
title_fullStr Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
title_full_unstemmed Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
title_sort immune-checkpoint protein vista critically regulates the il-23/il-17 inflammatory axis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/1b0571cb47a145ed901429ee57439f62
work_keys_str_mv AT nali immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT wenwenxu immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT yingyuan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT natarajanayithan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT yasutomoimai immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT xuesongwu immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT hallimiller immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT michaelolson immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT yunfengfeng immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT yinahhuang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT maryjoturk immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT samuelthwang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT subramaniammalarkannan immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
AT liwang immunecheckpointproteinvistacriticallyregulatestheil23il17inflammatoryaxis
_version_ 1718394910382489600